RDNT

RadNet, Inc. 10-Q Summary: Period Ended June 30, 2009

Business Context and Reporting Period

This is a Quarterly Report (Form 10-Q) for RadNet, Inc., a provider of diagnostic imaging services operating 175 facilities across seven states. The report covers the three and six months ended June 30, 2009. The company operates as a single segment, offering MRI, CT, PET, and other imaging services. RadNet consolidates the results of Beverly Radiology Medical Group III (BRMG), a variable interest entity owned indirectly by the CEO.

Key Financial Metrics

Note: Cash and cash equivalents were $0 at June 30, 2009.

Material Changes vs. Prior Period

• Revenue Growth: Net revenue increased 3.6% ($4.6 million) for the quarter and 7.8% ($18.7 million) for the six months compared to the prior year periods. Growth was driven by increased procedure volumes at existing facilities and revenue from newly acquired centers.
• Profitability Improvement: Net loss attributable to common shareholders narrowed significantly. For the six months ended June 30, 2009, the loss was $1.2 million compared to $7.6 million in the prior year period. Operating income increased to $19.0 million (6 months) from $13.5 million.
• Expense Management: Salaries and professional reading fees (excluding stock comp) decreased 2.8% at comparable centers due to cost-cutting measures. However, share-based compensation increased 151.7% ($1.5 million) for the quarter due to new option grants.
• Bad Debt Provision: The provision for bad debts increased to 6.4% of revenue (quarter) and 6.3% (six months) from 5.6% in the prior year, reflecting economic slowdown concerns.
• Acquisition Activity: The company acquired nine imaging centers in New Jersey for $2.1 million, resulting in a $1.4 million "gain on bargain purchase" due to the seller's liquidation status.

Guidance, Outlook, and Risks

• Liquidity Outlook: Management believes it will generate sufficient cash to satisfy obligations for the next twelve months through strategic plans and debt restructuring, despite operating in a capital-intensive industry with an equity deficit.
• Debt Restructuring: In Q1 2009, the company modified two interest rate swaps ("blend and extend"), reducing the fixed LIBOR rate and extending maturity by 36 months. This resulted in an estimated annualized cash interest savings of $2.9 million. However, $6.1 million of negative fair value from the original swaps is being amortized into interest expense through November 2009.
• Strategic Focus: The company is focusing on maximizing performance at existing facilities, profitable contracting, expanding MRI/CT/PET applications, and optimizing efficiencies.
• Risks: Key risks include the economic slowdown affecting patient collections, changes in third-party reimbursement rates, regulatory changes, and the company's high leverage and fixed-cost structure.

Investor Verification Checklist

• Cash Position: Verify the sustainability of operations with $0 cash and cash equivalents on the balance sheet, relying entirely on operating cash flow and credit facilities.
• Debt Covenants: Review the specific terms of the $405 million senior secured credit facility to ensure compliance with minimum fixed charge coverage and leverage ratios.
• Bad Debt Trends: Monitor the increasing provision for bad debts (6.3% of revenue) as a leading indicator of collection difficulties in the current economic climate.
• Interest Expense Volatility: Assess the impact of the $3.1 million amortization of Other Comprehensive Income (OCI) related to interest rate swap modifications on future earnings.
• Acquisition Integration: Evaluate the performance of the nine New Jersey centers acquired in June 2009 and the validity of the $1.4 million bargain purchase gain.